# HSBC UK Screened Equity UCITS ETF Accum GBP (HSUK) **Page:** https://fundology.uk/fund/hsuk · ISIN IE00BKY53D40 ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 13/11/2026, HSUK (HSBC UK Screened Equity UCITS ETF Accum GBP, ISIN IE00BKY53D40) closed at £25.26 on the London Stock Exchange. Its ongoing charge is 0.42% a year (about £42 on £10,000). Over the five years to 13/11/2026 its total return was +37.8%, or +7.6% after UK CPIH inflation. ## Summary HSBC UK Screened Equity UCITS ETF Accum GBP is an exchange-traded fund (ETF) from HSBC, launched in 2020. It tracks the FTSE UK ESG Low Carbon Select Index. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.42% a year — about £42 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. Latest close: **£25.26** (13/11/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | HSUK | | ISIN | IE00BKY53D40 | | Category | Sustainable & clean energy | | Type | ETF | | Provider | HSBC | | Tracks | FTSE UK ESG Low Carbon Select Index | | Income | Accumulating | | Ongoing charge | 0.42% a year (£42 per £10,000) | | Fund size | £20.7m | | Launched | 2020 | | Domicile | Ireland | | UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 08/10/2020 | ## Past returns (periods to 13/11/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | +9.97% | +6.08% | income reinvested | | 3 years | +60.11% | +44.66% | income reinvested | | 5 years | +37.80% | +7.56% | income reinvested | Returns: as reported (delayed data). Inflation: UK CPIH, latest month published. ## Calendar-year returns Calendar-year returns of HSBC UK Screened Equity UCITS ETF Accum GBP in pounds (price, with income reinvested in the fund): 2022 −6.1%, 2023 +2.5%, 2024 +10.3%, 2025 +26.5%; 2026 to 13/11/2026 +10.0%. Returns of HSBC UK Screened Equity UCITS ETF Accum GBP in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +11.5%; to 30/09/2025: +14.9%; to 30/09/2024: +13.8%; to 30/09/2023: +9.0%; to 30/09/2022: −6.0%. | Year | Return | After CPIH inflation | Measured as | |---|---|---|---| | 2022 | -6.1% | -14.0% | Price | | 2023 | +2.5% | -1.5% | Price | | 2024 | +10.3% | +6.6% | Price | | 2025 | +26.5% | +22.1% | Price | | 2026 to 13/11/2026 | +10.0% | +6.5% | Price | ## Risk metrics | Window | Volatility | Max drawdown | |---|---|---| | 1 year | 15.99% | -12.24% | | 3 years | 13.29% | -12.24% | | 5 years | 14.01% | -13.72% | ## Largest fall Volatility of HSBC UK Screened Equity UCITS ETF Accum GBP in pounds, annualised from weekly returns to 13/11/2026: 16.0% over 1 year, 13.3% over 3 years, 14.0% over 5 years. Largest fall in the price of HSBC UK Screened Equity UCITS ETF Accum GBP since November 2021, in pounds: −13.7% from 11/02/2022 to 14/10/2022. The lowest 12-month return of HSBC UK Screened Equity UCITS ETF Accum GBP in pounds (price, with income reinvested in the fund) since January 2021 was −8.1% (12 months to 28/10/2022); the highest was +31.0% (12 months to 09/01/2026). On 13/11/2026 the price of HSBC UK Screened Equity UCITS ETF Accum GBP was 0.5% below its highest weekly close since November 2021 (06/08/2026), in pounds. ## Charges compared with similar funds Ongoing charge of HSBC UK Screened Equity UCITS ETF Accum GBP 0.42% a year. Compared on 14/11/2026, 50 of the 177 other sustainable and clean-energy funds charge more, 2 the same and 125 less (share classes counted once). ## Funds tracking the same index 2 funds track FTSE UK ESG Low Carbon Select Index, this one included and share classes counted once; their ongoing charges range from 0.42% to 0.42% a year (13/11/2026). | Fund | Ongoing charge | 1 year | 3 years | 5 years | |---|---|---|---|---| | HSBC UK Screened Equity UCITS ETF Accum GBP (this fund) | 0.42% | +10.0% | +60.1% | +37.8% | | HSBC UK Screened Equity UCITS ETF GBP | 0.42% | +10.0% | — | — | Returns are as reported, in pounds, income reinvested unless marked "(price)". ## Charges & eligibility - Ongoing charges figure (OCF): **0.42%** per year (as of 09/10/2026) - Stocks and shares ISA eligible: usually (check with your platform) - SIPP eligible: usually (check with your provider) - ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify. ## What it holds As of 06/11/2026, HSUK holds 79 positions, according to its published holdings. The largest is GSK at 10.07% of the fund; the ten largest make up 57.0%. ### Top holdings Largest positions (as of 06/11/2026), as a percentage of the whole fund: | # | Holding | Ticker | Weight | |---|---|---|---| | 1 | GSK | [GSK](https://fundology.uk/stock/GSK) | 10.07% | | 2 | NatWest Group | [NWG](https://fundology.uk/stock/NWG) | 7.70% | | 3 | Diageo | [DGE](https://fundology.uk/stock/DGE) | 7.58% | | 4 | AstraZeneca | [AZN](https://fundology.uk/stock/AZN) | 6.65% | | 5 | Barclays | [BARC](https://fundology.uk/stock/BARC) | 6.02% | | 6 | Experian | [EXPN](https://fundology.uk/stock/EXPN) | 4.50% | | 7 | London Stock Exchange Group | [LSEG](https://fundology.uk/stock/LSEG) | 4.24% | | 8 | Aviva | [AV.](https://fundology.uk/stock/AV.) | 3.90% | | 9 | Sage Group | [SGE](https://fundology.uk/stock/SGE) | 3.43% | | 10 | Coca-Cola Europacific Partners | [CCEP](https://fundology.uk/stock/CCEP) | 2.92% | ## Where it invests Shares of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed. ### By country Added up from the fund’s published holdings, as of 03/11/2026. | Country | Weight | |---|---| | United Kingdom | 93.1% | | Switzerland | 4.8% | | Hong Kong | 0.9% | | Greece | 0.5% | | Not classified | 0.6% | All 79 holdings: https://fundology.uk/fund/hsuk/holdings ## Questions people ask **What is the ongoing charge of HSUK?** The ongoing charge of HSUK is 0.42% a year — about £42 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of HSBC UK Screened Equity UCITS ETF Accum GBP 0.42% a year. Compared on 14/11/2026, 50 of the 177 other sustainable and clean-energy funds charge more, 2 the same and 125 less (share classes counted once). **What does HSUK track?** HSUK tracks the FTSE UK ESG Low Carbon Select Index. **Is HSUK accumulating or distributing?** HSUK is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. **What is the ISIN of HSUK?** The ISIN of HSUK is IE00BKY53D40. An ISIN identifies one exact share class of a fund; HSUK is its ticker on the London Stock Exchange. **What does HSUK hold?** As of 06/11/2026, HSUK holds 79 positions, according to its published holdings. The largest is GSK at 10.07% of the fund; the ten largest make up 57.0%. Its ten largest holdings are GSK (10.07%), NatWest Group (7.70%), Diageo (7.58%), AstraZeneca (6.65%), Barclays (6.02%), Experian (4.50%), London Stock Exchange Group (4.24%), Aviva (3.90%), Sage Group (3.43%) and Coca-Cola Europacific Partners (2.92%). **What were HSUK’s returns in each of the last five years?** Calendar-year returns of HSUK in pounds (price, with income reinvested in the fund): 2022 −6.1%, 2023 +2.5%, 2024 +10.3%, 2025 +26.5%; 2026 to 13/11/2026 +10.0%. Past performance is not a guide to future returns. **How has HSUK done after inflation?** Over the five years to 13/11/2026 HSUK’s total return was +37.8%, or +7.6% after UK CPIH inflation. Past performance is not a guide to future returns. ## Fund documents - [Fund page at HSBC Asset Management](https://www.assetmanagement.hsbc.co.uk/en/individual-investor/funds/ie00bky53d40) - [Key investor information document (KIID)](https://www.assetmanagement.hsbc.co.uk/api/v1/download/document/ie00bky53d40/gb/en/kiid) - [Factsheet](https://www.assetmanagement.hsbc.co.uk/api/v1/download/document/ie00bky53d40/gb/en/factsheet) - Links checked 12/10/2026. --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.